John Gebeily

John Gebeily is a co-founder and general partner at Kadmos Capital, where they focus on investments in early-stage companies with high growth potential in the healthcare sector. With a strong background in pharmaceutical and biotechnology equity research, they previously served as a senior equity research analyst at the Royal Bank of Scotland and a lead portfolio manager at Audi Capital. John has also held various advisory and board positions, including at GlycanAge and Antiverse, while actively contributing to the microrobotics firm MovaLife. They possess extensive academic credentials, including a tech MBA from IE Business School and a pharmacy degree from New York State University and Lebanese American University.